Back to Trades
Cittadine Andrew
Chief Operating OfficerCIK 0001863624
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 5
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Cittadine Andrew, Chief Operating Officer, accounts for 5 disclosed filings worth $1.3M, all concentrated in Monopar Therapeutics (MNPR), active 2025–2026. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
5 loaded
| Jul 2 | MNPR Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Exercise | $213.8K |
| Apr 2 | MNPR Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Exercise | $86.1K |
| Jan 5 | MNPR Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Exercise | $123.4K |
| Dec 8 | MNPR Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Award | $681.1K |
| Oct 2 | MNPR Monopar Therapeutics | Cittadine Andrew | Chief Operating Officer | Exercise | $154.8K |
5 filings